MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Concordia Healthcare Corp Company Profile (TSE:CXR)

Consensus Ratings for Concordia Healthcare Corp (TSE:CXR) (?)
Ratings Breakdown: 2 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: C$65.00

Analysts' Ratings History for Concordia Healthcare Corp (TSE:CXR)
Show:
DateFirmActionRatingPrice TargetActions
6/28/2016TD SecuritiesLower Price TargetBuyC$45.00 -> C$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/27/2016RBC CapitalLower Price TargetOutperformC$51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/7/2016Goldman SachsInitiated CoverageNeutralC$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/21/2016Dundee SecuritiesLower Price TargetC$62.00 -> C$60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2015MackieDowngradeHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/9/2015ScotiabankBoost Price TargetOutperformC$90.00 -> C$100.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/9/2015Canaccord GenuityBoost Price TargetC$95.00 -> C$100.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2015LaurentianBoost Price TargetBuyC$101.50 -> C$106.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/20/2014LB SecuritiesInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for Concordia Healthcare Corp (TSE:CXR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/11/2016        
8/13/2015Q2$1.06$1.04ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/14/2014$0.19($0.03)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Concordia Healthcare Corp (TSE:CXR)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$1.86$1.86$1.86
Q2 20161$2.11$2.11$2.11
Q3 20161$2.19$2.19$2.19
Q4 20161$2.22$2.22$2.22
(Data provided by Zacks Investment Research)
Dividend History for Concordia Healthcare Corp (TSE:CXR)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
7/13/2016QuarterlyC$0.081.14%7/13/20167/29/20167/29/2016Tweet This Announcement  Share This Announcement on StockTwits
4/13/2016QuarterlyC$0.080.95%4/13/20164/29/20164/29/2016Tweet This Announcement  Share This Announcement on StockTwits
1/13/2016QuarterlyC$0.080.53%1/13/20161/29/20161/29/2016Tweet This Announcement  Share This Announcement on StockTwits
10/13/2015QuarterlyC$0.080.62%10/13/201510/30/201510/30/2015Tweet This Announcement  Share This Announcement on StockTwits
7/13/2015QuarterlyC$0.080.32%7/13/20157/31/20157/31/2015Tweet This Announcement  Share This Announcement on StockTwits
4/13/2015QuarterlyC$0.080.35%4/13/20154/30/20154/30/2015Tweet This Announcement  Share This Announcement on StockTwits
1/13/2015QuarterlyC$0.080.61%1/13/20151/31/20151/31/2015Tweet This Announcement  Share This Announcement on StockTwits
10/10/2014QuarterlyC$0.080.76%10/10/201410/31/201410/31/2014Tweet This Announcement  Share This Announcement on StockTwits
7/11/2014QuarterlyC$0.080.92%7/11/20147/31/20147/31/2014Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for Concordia Healthcare Corp (TSE:CXR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/1/2016Mark Laurence ThompsonDirectorBuy60C$28.77C$1,726.20Tweet This Trade  Share This Trade on StockTwits
11/17/2015Rochelle FuhrmannDirectorBuy2,000C$31.67C$63,340.00Tweet This Trade  Share This Trade on StockTwits
11/17/2015Wayne Walter KreppnerInsiderBuy3,000C$43.67C$131,010.00Tweet This Trade  Share This Trade on StockTwits
11/16/2015Mark Laurence ThompsonDirectorBuy23,150C$43.36C$1,003,702.98Tweet This Trade  Share This Trade on StockTwits
10/27/2015Edward BorkowskiDirectorBuy4,000C$30.43C$121,720.00Tweet This Trade  Share This Trade on StockTwits
7/23/2015Jordan KupinskyDirectorSell43,000C$103.70C$4,459,272.00Tweet This Trade  Share This Trade on StockTwits
7/17/2015Wayne Walter KreppnerInsiderSell4,800C$103.00C$494,400.00Tweet This Trade  Share This Trade on StockTwits
7/3/2015Jordan KupinskyDirectorSell10,800C$92.21C$995,884.20Tweet This Trade  Share This Trade on StockTwits
7/2/2015Jordan KupinskyDirectorSell45,900C$92.05C$4,224,934.35Tweet This Trade  Share This Trade on StockTwits
6/26/2015Robert Steven AltmanInsiderSell62,500C$93.93C$5,870,893.75Tweet This Trade  Share This Trade on StockTwits
6/22/2015John-Michel HussDirectorSell5,000C$92.00C$460,000.00Tweet This Trade  Share This Trade on StockTwits
6/19/2015John-Michel HussDirectorSell4,300C$90.00C$387,000.00Tweet This Trade  Share This Trade on StockTwits
6/11/2015John-Michel HussDirectorSell4,500C$90.02C$405,076.50Tweet This Trade  Share This Trade on StockTwits
5/27/2015Saldanha Adrian DeInsiderBuy1,000C$80.61C$80,610.00Tweet This Trade  Share This Trade on StockTwits
5/19/2015Adeel AhmadInsiderSell25,000C$83.80C$2,094,890.00Tweet This Trade  Share This Trade on StockTwits
10/31/2014James Christopher ReebalsDirectorSell7,500C$37.25C$279,360.75Tweet This Trade  Share This Trade on StockTwits
10/30/2014James Christopher ReebalsDirectorSell7,500C$37.06C$277,926.75Tweet This Trade  Share This Trade on StockTwits
10/29/2014James Christopher ReebalsDirectorSell5,000C$37.07C$185,336.50Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Concordia Healthcare Corp (TSE:CXR)
DateHeadline
06/30/16 06:00 AMConcordia International Corp. Announces FDA Approval for New Photofrin® Laser - [CNW Group] - Concordia International Corp. Announces FDA Approval for New Photofrin® Laser
06/29/16 01:09 PMEdited Transcript of CXR.TO earnings conference call or presentation 13-May-16 12:30pm GMT -
06/28/16 08:36 PMConcordia Healthcare Corp (TSE:CXR) price target dropped to $37 as disclosed today by TD Securities
06/28/16 08:22 AMConcordia Healthcare Corp (TSE:CXR) price target increased to $51, reported today by RBC Capital Markets
06/28/16 06:00 AMConcordia Healthcare Corp. Announces Name Change to Concordia International Corp. and Comments on Brexit's Impact on the Company's Business - [PR Newswire] - OAKVILLE, ON, June 28, 2016 /PRNewswire/ - Concordia Healthcare Corp. ("Concordia" or the "Company") (CXRX) (CXR.TO), an international pharmaceutical company focused on legacy pharmaceutical products and orphan drugs, today announced it has changed its name to Concordia International Corp. The name change was previously approved by the Board of Directors of the Company and the Company's shareholders. It is expected that the common shares of the Company will begin trading under the new name on June 30, 2016. The Company's stock symbol will remain CXR on the TSX and CXRX on NASDAQ. "The name Concordia International Corp. better reflects the global nature of our business," said Mark Thompson, Chairman and CEO of Concordia.
06/27/16 08:00 AMAre Analysts Bearish Concordia Healthcare Corp (TSE:CXR) After Last Week? - Engelwood Daily
06/24/16 03:37 PMCanada shares lower at close of trade; S&P/TSX Composite down 1.69% - Investing.com UK
06/24/16 10:15 AMCanadian Stocks Are Sinking, But Gold Shines Post Brexit -- Canadian Commentary - Nasdaq
06/22/16 08:12 AMConcordia Healthcare Corp (TSE:CXR) price target increased to $73 as issued in a report today by RBC Capital Markets
06/21/16 03:20 PMConcordia Healthcare Corp (TSE:CXR) price target increased to $73 as issued in a report today by RBC Capital Markets - Breaking Finance News
06/19/16 07:59 AMConcordia Healthcare Announces PDT with Photofrin® Data and Provides Corporate Update - PR Newswire (press release)
06/13/16 09:49 AMCONCORDIA HEALTHCARE CORP T.CXR
06/08/16 10:28 AMCanadian Stocks Are Paring Early Gains -- Canadian Commentary - Nasdaq
06/07/16 03:37 PMCanada stocks higher at close of trade; S&P/TSX Composite up 0.63% - Investing.com
06/07/16 11:08 AMTerm Sheet -- Monday, June 7 - Fortune
06/05/16 10:13 AMAre Analysts Bullish Concordia Healthcare Corp (TSE:CXR) After Last Week? - HNN
06/03/16 03:43 PMCanada stocks higher at close of trade; S&P/TSX Composite up 0.64% - Investing.com
06/03/16 10:40 AMCanadian Stocks Are Up As Metal Prices Surge -- Canadian Commentary - Nasdaq
06/03/16 10:40 AMTerm Sheet -- Friday, June 3 - Fortune
06/02/16 03:38 PMCanada stocks higher at close of trade; S&P/TSX Composite up 0.52% - Investing.com - Investing.comCanada stocks higher at close of trade; S&P/TSX Composite up 0.52%Investing.comThe worst performers of the session were Concordia Healthcare (TO:CXR), which fell 9.30% or 3.77 points to trade at 36.75 at the close. Canadian Energy Services & Technology Corp (TO:CEU) declined 2.51% or 0.090 points to end at 3.500 and Centerra ...and more »
06/01/16 03:42 PMIs Concordia Healthcare Corp. Too Cheap to Ignore? - The Motley Fool Canada - Is Concordia Healthcare Corp. Too Cheap to Ignore?The Motley Fool CanadaTalk about a highly volatile stock! Within a year, Concordia Healthcare Corp. (TSX:CXR)(NASDAQ:CXRX) has declined more than 60% from over $100 to $40 per share today. In fact, in just a single day on May 31 Concordia's shares fell more than 7%.
05/31/16 03:37 PMCanada stocks lower at close of trade; S&P/TSX Composite down 0.15% - Investing.com - Investing.comCanada stocks lower at close of trade; S&P/TSX Composite down 0.15%Investing.comThe worst performers of the session were Concordia Healthcare (TO:CXR), which fell 7.65% or 3.34 points to trade at 40.34 at the close. ProMetic Life Sciences Inc. (TO:PLI) declined 3.78% or 0.110 points to end at 2.800 and Westshore Terminals ...and more »
05/27/16 11:14 AMCanadian Stocks Are Climbing In Early Action -- Canadian Commentary - Nasdaq - Canadian Stocks Are Climbing In Early Action -- Canadian CommentaryNasdaqConcordia Healthcare (CXR.TO) is climbing 2.90 percent and Extendicare (EXE.TO) is adding 0.46 percent. Valeant Pharmaceuticals International (VRX.TO) is surging 8.60 percent. The Globe and Mail reported that the company rejected a joint takeover bid ...and more »
05/26/16 10:16 AMHow Valeant's woes have upset the Canadian health care apple cart - Financial Post - Financial PostHow Valeant's woes have upset the Canadian health care apple cartFinancial PostConcordia Healthcare Corp. (TSE:CXR) is down 69 per cent from its September 2015 high of $110.60 and is now wallowing around the $40 per share range. The company was the target of successive negative attacks that drew comparisons to it as “Baby ...and more »
05/26/16 10:16 AMCanadian Stocks Are Extending Gains On Crude Strength -- Canadian Commentary - Nasdaq - Canadian Stocks Are Extending Gains On Crude Strength -- Canadian CommentaryNasdaqDescartes Systems Group (DSG.TO) is falling 0.30 percent. The company reported first quarter EPS of $0.08, compared to $0.06 a year ago. The Capped Healthcare Index is losing 0.31 percent. Concordia Healthcare (CXR.TO) is weakening by 1.65 percent ...
05/20/16 07:40 AMThe Other Canadian Drug Company That Has Pushed Up Drug Prices -
05/17/16 07:41 AMConcordia Healthcare Corp. breached its 50 day moving average in a Bullish Manner : CXR-CA : May 17, 2016 -
05/13/16 06:07 AMQ1 2016 Concordia Healthcare Corp Earnings Release - Before Market Open -
05/02/16 09:29 AMTerm Sheet — Monday, May 2 -
05/02/16 08:12 AMConcordia Healthcare Corp. breached its 50 day moving average in a Bearish Manner : CXR-CA : May 2, 2016 -
04/29/16 11:53 AMConcordia Is Working With Greenhill to Seek Buyout Bidders -
04/22/16 08:12 AM[$$] Blackstone Considers Deal for Concordia Healthcare -
02/26/16 11:34 AMCanadian Stocks Are Rising On Mining & Energy Strength -- Canadian Commentary - Nasdaq - Canadian Stocks Are Rising On Mining & Energy Strength -- Canadian CommentaryNasdaqTO) is rising 1.70 percent. The Capped Health Care Index is up 0.07 percent. Concordia Healthcare (CXR.TO) is gaining 0.86 percent. Extendicare (EXE.TO) is lower by 0.89 percent. The company reported that its full year revenues rose 20 percent to C$979 ...and more »
02/26/16 11:34 AMToday Concordia Healthcare Corp Stock Rises - Franklin Independent - Today Concordia Healthcare Corp Stock RisesFranklin IndependentThe stock of Concordia Healthcare Corp (TSE:CXR) is a huge mover today! The stock increased 4.66% or $1.84 on February 24, hitting $41.34. About 453,303 shares traded hands. Concordia Healthcare Corp (TSE:CXR) has declined 61.72% since July 17, ...Are Analysts Bullish Concordia Healthcare Corp (TSE:CXR) After Last Week?Stock Callerall 5 news articles »
02/15/16 01:55 PMWhat's Propelling Concordia Healthcare Corp to Increase So Much? - Sonoran Weekly Review - What's Propelling Concordia Healthcare Corp to Increase So Much?Sonoran Weekly ReviewThe stock of Concordia Healthcare Corp (TSE:CXR) is a huge mover today! The stock increased 8.22% or $2.77 on February 12, hitting $36.45. About 448,993 shares traded hands. Concordia Healthcare Corp (TSE:CXR) has declined 58.72% since July 9, ...and more »
02/09/16 01:47 PMWhat's Next for Concordia Healthcare Corp After Today's Gap Down? - Sonoran Weekly Review - What's Next for Concordia Healthcare Corp After Today's Gap Down?Sonoran Weekly ReviewThe stock of Concordia Healthcare Corp (TSE:CXR) gapped down by $0.26 today and has $36.42 target or 5.00% below today's $38.34 share price. The 5 months technical chart setup indicates high risk for the $1.97 billion company. The gap down was ...and more »
02/03/16 12:49 PMA Reversal for Concordia Healthcare Corp Is Not Near. The Stock Declines Again - WallStreet.org - A Reversal for Concordia Healthcare Corp Is Not Near. The Stock Declines AgainWallStreet.orgThe stock of Concordia Healthcare Corp (TSE:CXR) is a huge mover today! The stock is down 3.82% or $1.51 after the news, hitting $37.99 per share. About 126,418 shares traded hands. Concordia Healthcare Corp (TSE:CXR) has declined 57.45% since ...
01/29/16 12:43 PMCanadian Stocks Are Extending Gains After BoJ Move -- Canadian Commentary - Nasdaq - Canadian Stocks Are Extending Gains After BoJ Move -- Canadian CommentaryNasdaqConcordia Healthcare (CXR.TO) is gaining 4.77 percent and Valeant Pharmaceuticals International (VRX.TO) is rising 5.08 percent. Extendicare (EXE.TO) is also adding 0.77 percent. The Diversified Metal and Mining Index is advancing 2.63 percent ...and more »
01/25/16 06:56 PMAltaGas - Mispriced And Misunderstood - Seeking Alpha - Seeking AlphaAltaGas - Mispriced And MisunderstoodSeeking AlphaThis is how Concordia Healthcare TSX:CXR or (NASDAQ:CXRX) came to my attention. It was during the research to write the option that I realized CXR actually might be a great opportunity for far more than just an option, and it has been. Altagas TSX:ALA ...and more »
01/22/16 11:45 AMConcordia Healthcare Corp. (CXR.TO) - Concordia Healthcare Corp. operates as an integrated healthcare company that focuses on legacy pharmaceutical products and orphan drugs for the diabetic market. The company operates through three divisions: Legacy Pharmaceuticals, Specialty Healthcare ...
01/20/16 11:45 AMCanadian Stocks Are Sinking As Crude Prices Drop -- Canadian Commentary - Nasdaq - Canadian Stocks Are Sinking As Crude Prices Drop -- Canadian CommentaryNasdaqThe Capped Health Care Index is lower by 4.12 percent. Concordia Healthcare (CXR.TO) is losing 6.77 percent and Extendicare (EXE.TO) is down 1.83 percent. Valeant Pharmaceuticals International (VRX.TO) is also falling 3.48 percent. The heavyweight ...and more »
01/17/16 06:24 PMConcordia Healthcare to Present at CIBC Investor Conference - PR Newswire (press release) - Concordia Healthcare to Present at CIBC Investor ConferencePR Newswire (press release)OAKVILLE, ON, Jan. 15, 2016 /PRNewswire/ - Concordia Healthcare Corp. ("Concordia" or the "Company") (NASDAQ: CXRX) (TSX: CXR), an international pharmaceutical company focused on legacy pharmaceutical products and orphan drugs, announced ...and more »
01/12/16 08:00 AMConcordia Healthcare Corp. – Value Analysis (TORONTO:CXR) : January 12, 2016 -
01/11/16 04:00 PMConcordia Healthcare Provides Corporate Update - [CNW Group] - Concordia Healthcare Provides Corporate Update
12/15/15 11:10 AMConcordia Healthcare Announces Intent to Repay US$45 Million Debt, and Inclusion to Nasdaq Biotech Index - [PR Newswire] - OAKVILLE, ON, Dec. 15, 2015 /PRNewswire/ - Concordia Healthcare Corp. ("Concordia" or the "Company") (CXRX) (CXR.TO), an international pharmaceutical company focused on legacy pharmaceutical products and orphan drugs, announced today that it intends to pay down US$11.25 million of its US$45 million senior unsecured bridge loan, and US$33.75 million of its US$135 million senior unsecured bridge loan. The US$45 million unsecured bridge loan and the US$135 million unsecured bridge loan have two and seven-year maturity dates, respectively. "Our intent to pay down this portion of our senior unsecured bridge loans demonstrates our commitment to reduce our debt," said Mark Thompson, Concordia's Chairman and Chief Executive Officer.
12/03/15 10:11 AMConcordia Healthcare Corp. Earnings Q3, 2015 -
11/23/15 06:00 AMConcordia Healthcare Announces Launch of First Pipeline Product, and Positive Amendment to Earn-out Terms of AMCo Agreement - [CNW Group] - Concordia Healthcare Announces Launch of First Pipeline Product, and Positive Amendment to Earn-out Terms of AMCo Agreement
11/22/15 11:21 PMConcerns Over Valeant Spread to Other Drug Makers -
11/12/15 04:00 PMConcordia Healthcare Announces Third Quarter 2015 Results - [CNW Group] - Concordia Healthcare Announces Third Quarter 2015 Results
11/12/15 06:07 AMQ3 2015 Concordia Healthcare Corp Earnings Release - After Market Close -
About Concordia Healthcare Corp

Concordia Healthcare Corp logoConcordia Healthcare Corp. is a Canada-based diverse healthcare company. The Company is focused on legacy pharmaceutical products and orphan drugs. The Company operates through three segments, which includes Legacy Pharmaceutical Division, Concordia Pharmaceuticals Inc., which consists of 23 products, including Nilandron, for the treatment of metastatic prostate cancer; Dibenzyline, for the treatment of pheochromocytoma; Lanoxin, for the treatment of mild-to-moderate heart failure and atrial fibrillation; Plaquenil, for the treatment of lupus and rheumatoid arthritis; Donnatal, for the treatment of irritable bowel syndrome, and Zonegran (zonisamide), for treatment of partial seizures in adults with epilepsy. Its Specialty Healthcare Distribution (SHD) Division, Complete Medical Homecare, is engaged in the distribution of medical supplies focused on diabetes and related conditions. Its Orphan Drugs Division, Concordia Laboratories Inc., is engaged in the manufacture of PHOTOFRIN.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: TSE
  • Symbol: CXR
  • CUSIP:
Key Metrics:
  • Previous Close: $27.83
  • 50 Day Moving Average: $33.71
  • 200 Day Moving Average: $38.81
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $1.42B
  • Current Quarter EPS Consensus Estimate: $6.18 EPS
Additional Links:
Concordia Healthcare Corp (TSE:CXR) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha